AI assistant
Sending…
Microbot Medical Inc. — Director's Dealing 2013
Apr 9, 2013
33819_dirs_2013-04-09_9750113b-f32e-4d60-b501-a28c13f8f2cb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2013-04-01
Reporting Person: WEISSMAN IRVING (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-04-01 | Common Stock | A | 1404 | $1.00 | Acquired | 117382 | Direct |
| 2013-04-01 | Common Stock | A | 7226 | $0.00 | Acquired | 124608 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 19012 | Indirect |
Footnotes
F1: The $1.00 per share price was the stock option exercise price for shares granted to Dr. Weissman on April 1, 2003.
F2: Includes anniversary equity grant of 10,000 restricted stock units, vesting 100% on October 1, 2013, the one year anniversary of the grant.
F3: Quarterly retainer paid to Dr. Weissman in shares of common stock as consideration for his continued service on the Company's Scientific Advisory Board.
F4: Includes 10,508 shares held in trust for Dr. Weissman's grandchildren to which Dr. Weissman disclaims beneficial ownership.
More from Microbot Medical Inc.
Regulatory Filings
2026
Jun 2
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 5
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 13